TNGX Tango Therapeutics, Inc.
Nasdaq · SEC CIK 1819133 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $15.68M 15 sales by 4 insiders
- Filings on record
- 111 since 2021-08-16, latest 2026-09-03 16:01
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| TRV GP IV, LLC | 10% | — | $8.86M |
| Crystal Adam | Pres, R, D | — | $6.33M |
| Weber Barbara | Dir, Executive COB | — | $374.4K |
| Beckman Daniella | CFO | — | $126.6K |
| Ketchum John B | Dir | — | — |
| Peters Malte | Pres, CEO, Dir | — | — |
| Rothenberg Mace | Dir | — | — |
| Gall Matthew | CFO | — | — |
| Lee Sung | Dir | — | — |
| Calhoun Lesley Ann | Dir | — | — |
Transactions 107
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-02 | 2023-03-01 | TNGX | Crystal Adam | See Remarks | A - Grant | $0.00 | +81.2K | 81.2K | New | $0 |
| D | 2023-03-02 | 2023-03-01 | TNGX | Weber Barbara | CEO, Dir | A - Grant | $0.00 | +89.5K | 1.46M | +7% | $0 |
| D | 2023-03-02 | 2023-03-01 | TNGX | Beckman Daniella | CFO | A - Grant | $0.00 | +32.8K | 96.7K | +51% | $0 |
| D | 2023-03-02 | 2023-03-01 | TNGX | Huang Alan | CSO | A - Grant | $0.00 | +31.7K | 167.6K | +23% | $0 |
| D | 2023-03-02 | 2023-03-01 | TNGX | Barry Douglas | GC | A - Grant | $0.00 | +23.9K | 23.9K | New | $0 |
| M | 2022-10-13 | 2022-10-11+ | TNGX | Boxer Capital, LLC | 10% | P - Purchase | $4.41 | +237.0K | 268.5K | +752% | +$1.04M |
| M | 2022-10-06 | 2022-10-04+ | TNGX | LEWIS JOSEPH | 10% | P - Purchase | $3.92 | +182.0K | 6.94M | +3% | +$714.1K |
Purchase Sale Sale after option exercise All abbreviations